vs

Side-by-side financial comparison of Invesco (IVZ) and SS&C Technologies Holdings Inc (SSNC). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.6B, roughly 1.0× SS&C Technologies Holdings Inc). SS&C Technologies Holdings Inc runs the higher net margin — 13.7% vs -58.9%, a 72.6% gap on every dollar of revenue. On growth, SS&C Technologies Holdings Inc posted the faster year-over-year revenue change (8.8% vs 6.2%). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 6.5%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

SS&C Technologies Holdings, Inc. is an American multinational holding company headquartered in Windsor, Connecticut, that sells software and software as a service to the financial services industry. The company has offices in the Americas, Europe, Asia, Africa and Australia.

IVZ vs SSNC — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.0× larger
IVZ
$1.7B
$1.6B
SSNC
Growing faster (revenue YoY)
SSNC
SSNC
+2.6% gap
SSNC
8.8%
6.2%
IVZ
Higher net margin
SSNC
SSNC
72.6% more per $
SSNC
13.7%
-58.9%
IVZ
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
6.5%
SSNC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IVZ
IVZ
SSNC
SSNC
Revenue
$1.7B
$1.6B
Net Profit
$-995.9M
$226.1M
Gross Margin
48.7%
Operating Margin
-86.2%
24.2%
Net Margin
-58.9%
13.7%
Revenue YoY
6.2%
8.8%
Net Profit YoY
-575.8%
6.2%
EPS (diluted)
$-2.61
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
SSNC
SSNC
Q1 26
$1.6B
Q4 25
$1.7B
$1.7B
Q3 25
$1.6B
$1.6B
Q2 25
$1.5B
$1.5B
Q1 25
$1.5B
$1.5B
Q4 24
$1.6B
$1.5B
Q3 24
$1.5B
$1.5B
Q2 24
$1.5B
$1.5B
Net Profit
IVZ
IVZ
SSNC
SSNC
Q1 26
$226.1M
Q4 25
$-995.9M
$193.1M
Q3 25
$356.4M
$210.0M
Q2 25
$197.4M
$180.8M
Q1 25
$171.1M
$213.0M
Q4 24
$209.3M
$248.2M
Q3 24
$55.0M
$164.4M
Q2 24
$132.2M
$190.3M
Gross Margin
IVZ
IVZ
SSNC
SSNC
Q1 26
48.7%
Q4 25
47.8%
Q3 25
47.7%
Q2 25
48.0%
Q1 25
49.3%
Q4 24
49.3%
Q3 24
48.0%
Q2 24
48.1%
Operating Margin
IVZ
IVZ
SSNC
SSNC
Q1 26
24.2%
Q4 25
-86.2%
22.3%
Q3 25
16.5%
23.3%
Q2 25
14.1%
22.4%
Q1 25
18.1%
23.6%
Q4 24
19.6%
23.4%
Q3 24
6.6%
22.2%
Q2 24
13.9%
22.6%
Net Margin
IVZ
IVZ
SSNC
SSNC
Q1 26
13.7%
Q4 25
-58.9%
11.7%
Q3 25
21.7%
13.4%
Q2 25
13.0%
11.8%
Q1 25
11.2%
14.1%
Q4 24
13.1%
16.2%
Q3 24
3.6%
11.2%
Q2 24
8.9%
13.1%
EPS (diluted)
IVZ
IVZ
SSNC
SSNC
Q1 26
$0.91
Q4 25
$-2.61
$0.76
Q3 25
$0.66
$0.83
Q2 25
$-0.03
$0.72
Q1 25
$0.38
$0.84
Q4 24
$0.46
$0.98
Q3 24
$0.12
$0.65
Q2 24
$0.29
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
SSNC
SSNC
Cash + ST InvestmentsLiquidity on hand
$1.0B
$420.9M
Total DebtLower is stronger
$1.8B
$7.4B
Stockholders' EquityBook value
$12.2B
$6.9B
Total Assets
$27.1B
$20.3B
Debt / EquityLower = less leverage
0.15×
1.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
SSNC
SSNC
Q1 26
$420.9M
Q4 25
$1.0B
$462.1M
Q3 25
$973.1M
$388.3M
Q2 25
$922.7M
$480.3M
Q1 25
$821.7M
$515.0M
Q4 24
$986.5M
$567.1M
Q3 24
$1.0B
$694.7M
Q2 24
$878.5M
$462.7M
Total Debt
IVZ
IVZ
SSNC
SSNC
Q1 26
$7.4B
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Stockholders' Equity
IVZ
IVZ
SSNC
SSNC
Q1 26
$6.9B
Q4 25
$12.2B
$6.9B
Q3 25
$14.0B
$6.9B
Q2 25
$13.9B
$6.9B
Q1 25
$14.7B
$6.8B
Q4 24
$14.6B
$6.5B
Q3 24
$14.8B
$6.8B
Q2 24
$14.6B
$6.4B
Total Assets
IVZ
IVZ
SSNC
SSNC
Q1 26
$20.3B
Q4 25
$27.1B
$20.7B
Q3 25
$28.4B
$19.5B
Q2 25
$28.5B
$19.0B
Q1 25
$28.1B
$20.4B
Q4 24
$27.0B
$19.0B
Q3 24
$27.5B
$18.4B
Q2 24
$27.2B
$16.9B
Debt / Equity
IVZ
IVZ
SSNC
SSNC
Q1 26
1.08×
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
SSNC
SSNC
Operating Cash FlowLast quarter
$455.8M
$299.7M
Free Cash FlowOCF − Capex
$432.2M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
1.4%
0.0%
Cash ConversionOCF / Net Profit
1.33×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
SSNC
SSNC
Q1 26
$299.7M
Q4 25
$455.8M
$643.5M
Q3 25
$606.2M
$456.2M
Q2 25
$547.9M
$372.9M
Q1 25
$-84.6M
$272.2M
Q4 24
$316.9M
$486.6M
Q3 24
$438.4M
$336.6M
Q2 24
$489.1M
$384.9M
Free Cash Flow
IVZ
IVZ
SSNC
SSNC
Q1 26
Q4 25
$432.2M
$633.0M
Q3 25
$586.4M
$421.5M
Q2 25
$530.4M
$350.0M
Q1 25
$-108.0M
$259.5M
Q4 24
$309.9M
$466.9M
Q3 24
$410.0M
$310.7M
Q2 24
$462.4M
$374.9M
FCF Margin
IVZ
IVZ
SSNC
SSNC
Q1 26
Q4 25
25.5%
38.3%
Q3 25
35.7%
26.9%
Q2 25
35.0%
22.8%
Q1 25
-7.1%
17.1%
Q4 24
19.5%
30.5%
Q3 24
27.1%
21.2%
Q2 24
31.2%
25.8%
Capex Intensity
IVZ
IVZ
SSNC
SSNC
Q1 26
0.0%
Q4 25
1.4%
0.6%
Q3 25
1.2%
2.2%
Q2 25
1.2%
1.5%
Q1 25
1.5%
0.8%
Q4 24
0.4%
1.3%
Q3 24
1.9%
1.8%
Q2 24
1.8%
0.7%
Cash Conversion
IVZ
IVZ
SSNC
SSNC
Q1 26
1.33×
Q4 25
3.33×
Q3 25
1.70×
2.17×
Q2 25
2.78×
2.06×
Q1 25
-0.49×
1.28×
Q4 24
1.51×
1.96×
Q3 24
7.97×
2.05×
Q2 24
3.70×
2.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

SSNC
SSNC

Technology-enabled services$1.4B85%
License, maintenance and related$239.8M15%

Related Comparisons